The UK Competition and Markets Authority (CMA) has sent a letter to the Parliamentary Under-Secretary of State for Patient Safety, Women's Health and Mental Health, providing an update on its voluntary pricing initiative for fertility clinics. This initiative is designed to help patients better compare the prices of various fertility services.

In the letter, the CMA emphasized the importance of transparency in pricing for fertility treatments, which can often be complex and varied across different clinics. By making pricing information more accessible, the CMA believes that patients will be empowered to make more informed choices regarding their fertility care.

Additionally, the CMA reiterated its stance that the Human Fertilisation and Embryology Authority (HFEA) should be equipped with a broader range of regulatory tools. This flexibility could enhance the HFEA's ability to oversee fertility clinics effectively and ensure that patients receive fair treatment and clear information about their options.